本页面由Tiger Trade Technology Pte. Ltd.提供服务

Strata Critical Medical, Inc.

5.97
-0.2700-4.33%
盘后5.970.00000.00%16:10 EDT
成交量:88.74万
成交额:531.30万
市值:5.28亿
市盈率:12.66
高:6.28
开:6.20
低:5.88
收:6.24
52周最高:6.50
52周最低:3.85
股本:8,846.68万
流通股本:5,821.71万
量比:0.96
换手率:1.52%
股息:- -
股息率:- -
每股收益(TTM):0.4716
每股收益(LYR):0.5037
净资产收益率:-9.22%
总资产收益率:-1.86%
市净率:1.89
市盈率(LYR):11.85

数据加载中...

2026/08/20

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/17

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/04/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/03

重要事件披露

Form 8-K - Current report
2026/02/05

重要事件披露

Form 8-K - Current report
2025/12/03

重要事件披露

Form 8-K - Current report
2025/12/02

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/11/21

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]